ENDRA LIFE SCIENCES INC. Operating Expenses
ENDRA LIFE SCIENCES INC. (NDRA) reported Operating Expenses of $1.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. operating expenses for the quarter ending 2026-06-30 was $1.48M, a 14.00% increase year-over-year.
- ENDRA LIFE SCIENCES INC. operating expenses for the quarter ending 2026-03-31 was $2.17M, a 47.95% increase year-over-year.
- ENDRA LIFE SCIENCES INC. operating expenses for the quarter ending 2025-12-31 was $1.62M, a 62.25% decline year-over-year.
- ENDRA LIFE SCIENCES INC. operating expenses for the quarter ending 2025-09-30 was $1.37M, a 9.17% decline year-over-year.
- ENDRA LIFE SCIENCES INC. operating expenses for fiscal 2025 was $5.76M, a 46.72% decline from fiscal 2024.
- ENDRA LIFE SCIENCES INC. operating expenses for fiscal 2024 was $10.82M, a 2.82% increase from fiscal 2023.
- ENDRA LIFE SCIENCES INC. operating expenses for fiscal 2023 was $10.52M, a 20.04% decline from fiscal 2022.
- ENDRA LIFE SCIENCES INC. operating expenses for fiscal 2022 was $13.16M, a 14.43% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.48M 10-Q · filed 2026-08-14 | $3.66M 10-Q · filed 2026-08-14 | $5.28M derived: sum of 3 quarters · filed 2026-08-14 | $6.65M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $2.17M 10-Q · filed 2026-05-15 | $3.80M derived: sum of 2 quarters · filed 2026-05-15 | $5.17M derived: sum of 3 quarters · filed 2026-05-15 | $6.47M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $1.62M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $2.99M derived: sum of 2 quarters · filed 2026-03-31 | $4.29M derived: sum of 3 quarters · filed 2026-08-14 | $5.76M 10-K · filed 2026-03-31 | ||
| 2025-09-30 | $1.37M 10-Q · filed 2025-11-14 | $2.67M derived: sum of 2 quarters · filed 2026-08-14 | $4.14M 10-Q · filed 2025-11-14 | $8.44M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $1.30M 10-Q · filed 2026-08-14 | $2.77M 10-Q · filed 2026-08-14 | $7.07M derived: sum of 3 quarters · filed 2026-08-14 | $8.58M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $1.47M 10-Q · filed 2026-05-15 | $5.77M derived: sum of 2 quarters · filed 2026-05-15 | $7.28M derived: sum of 3 quarters · filed 2026-05-15 | $9.51M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.81M derived: sum of 2 quarters · filed 2026-03-31 | $8.04M derived: sum of 3 quarters · filed 2026-03-31 | $10.82M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | $1.51M 10-Q · filed 2025-11-14 | $3.74M derived: sum of 2 quarters · filed 2025-11-14 | $6.52M 10-Q · filed 2025-11-14 | $7.98M derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | $2.23M 10-Q · filed 2025-08-14 | $5.01M 10-Q · filed 2025-08-14 | $6.47M derived: sum of 3 quarters · filed 2025-08-14 | $9.60M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $2.78M 10-Q · filed 2025-05-15 | $4.24M derived: sum of 2 quarters · filed 2025-05-15 | $7.37M derived: sum of 3 quarters · filed 2025-05-15 | $10.36M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $1.46M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | $4.59M derived: sum of 2 quarters · filed 2025-04-07 | $7.58M derived: sum of 3 quarters · filed 2025-04-07 | $10.52M 10-K/A · filed 2025-04-07 | ||
| 2023-09-30 | $3.13M 10-Q/A · filed 2024-11-21 | $6.12M derived: sum of 2 quarters · filed 2024-11-21 | $9.06M 10-Q/A · filed 2024-11-21 | $12.38M derived: sum of 4 quarters · filed 2024-11-21 | ||
| 2023-06-30 | $2.99M 10-Q · filed 2024-08-14 | $5.93M 10-Q · filed 2024-08-14 | $9.25M derived: sum of 3 quarters · filed 2024-08-14 | $12.66M derived: sum of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $2.94M 10-Q · filed 2024-05-14 | $6.25M derived: sum of 2 quarters · filed 2024-05-14 | $9.67M derived: sum of 3 quarters · filed 2024-05-14 | $13.24M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $6.73M derived: sum of 2 quarters · filed 2024-03-28 | $10.30M derived: sum of 3 quarters · filed 2024-03-28 | $13.16M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $3.42M 10-Q · filed 2023-11-14 | $6.99M derived: sum of 2 quarters · filed 2023-11-14 | $9.84M 10-Q · filed 2023-11-14 | $12.92M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $3.57M 10-Q · filed 2023-08-14 | $6.43M 10-Q · filed 2023-08-14 | $9.50M derived: sum of 3 quarters · filed 2023-08-14 | $12.15M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $2.86M 10-Q · filed 2023-05-15 | $5.93M derived: sum of 2 quarters · filed 2023-05-15 | $8.58M derived: sum of 3 quarters · filed 2023-05-15 | $11.78M derived: sum of 4 quarters · filed 2023-05-15 | ||
| 2021-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $5.72M derived: sum of 2 quarters · filed 2023-03-16 | $8.92M derived: sum of 3 quarters · filed 2023-03-16 | $11.50M 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $2.65M 10-Q · filed 2022-11-14 | $5.85M derived: sum of 2 quarters · filed 2022-11-14 | $8.43M 10-Q · filed 2022-11-14 | $10.68M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $3.20M 10-Q · filed 2022-08-15 | $5.78M 10-Q · filed 2022-08-15 | $8.03M derived: sum of 3 quarters · filed 2022-08-15 | $11.29M derived: sum of 4 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $2.58M 10-Q · filed 2022-05-12 | $4.83M derived: sum of 2 quarters · filed 2022-05-12 | $8.09M derived: sum of 3 quarters · filed 2022-05-12 | $10.98M derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $5.51M derived: sum of 2 quarters · filed 2022-03-30 | $8.40M derived: sum of 3 quarters · filed 2022-03-30 | $11.50M 10-K · filed 2022-03-30 | ||
| 2020-09-30 | $3.26M 10-Q · filed 2021-11-15 | $6.15M derived: sum of 2 quarters · filed 2021-11-15 | $9.25M 10-Q · filed 2021-11-15 | $12.38M derived: sum of 4 quarters · filed 2021-11-15 | ||
| 2020-06-30 | $2.89M 10-Q · filed 2021-08-12 | $5.99M 10-Q · filed 2021-08-12 | $9.12M derived: sum of 3 quarters · filed 2021-08-12 | $11.76M derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $3.10M 10-Q · filed 2021-05-17 | $6.23M derived: sum of 2 quarters · filed 2021-05-17 | $8.87M derived: sum of 3 quarters · filed 2021-05-17 | $11.20M derived: sum of 4 quarters · filed 2021-05-17 | ||
| 2019-12-31 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $5.77M derived: sum of 2 quarters · filed 2021-03-25 | $8.10M derived: sum of 3 quarters · filed 2021-03-25 | $10.84M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $2.64M 10-Q · filed 2020-11-16 | $4.97M derived: sum of 2 quarters · filed 2020-11-16 | $7.71M 10-Q · filed 2020-11-16 | $9.72M derived: sum of 4 quarters · filed 2020-11-16 | ||
| 2019-06-30 | $2.33M 10-Q · filed 2020-08-14 | $2.33M 10-Q · filed 2019-08-08 | $5.07M 10-Q · filed 2020-08-14 | $7.08M derived: sum of 3 quarters · filed 2020-08-14 | $9.43M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $2.75M 10-Q · filed 2020-05-14 | $4.75M derived: sum of 2 quarters · filed 2020-05-14 | $7.11M derived: sum of 3 quarters · filed 2020-05-14 | $8.93M derived: sum of 4 quarters · filed 2020-05-14 | ||
| 2018-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $4.36M derived: sum of 2 quarters · filed 2020-03-26 | $6.18M derived: sum of 3 quarters · filed 2020-03-26 | $9.03M 10-K · filed 2020-03-26 | ||
| 2018-09-30 | $2.36M 10-Q · filed 2019-11-13 | $2.36M 10-Q · filed 2018-11-05 | $4.18M derived: sum of 2 quarters · filed 2019-11-13 | $7.02M 10-Q · filed 2019-11-13 | $9.32M derived: sum of 4 quarters · filed 2019-11-13 | |
| 2018-06-30 | $1.82M 10-Q · filed 2019-08-08 | $4.67M 10-Q · filed 2019-08-08 | $6.97M derived: sum of 3 quarters · filed 2019-08-08 | $8.05M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $2.84M 10-Q · filed 2019-05-14 | $5.14M derived: sum of 2 quarters · filed 2019-05-14 | $6.22M derived: sum of 3 quarters · filed 2019-05-14 | $7.29M derived: sum of 4 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | $3.38M derived: sum of 2 quarters · filed 2019-03-11 | $4.44M derived: sum of 3 quarters · filed 2019-03-11 | $4.80M 10-K · filed 2019-03-11 | ||
| 2017-09-30 | $1.08M 10-Q · filed 2018-11-05 | $2.14M derived: sum of 2 quarters · filed 2018-11-05 | $2.50M 10-Q · filed 2018-11-05 | $3.10M derived: sum of 4 quarters · filed 2018-11-05 | ||
| 2017-06-30 | $1.06M 10-Q · filed 2018-08-13 | $1.06M 10-Q · filed 2017-08-07 | $1.42M 10-Q · filed 2018-08-13 | $1.42M 10-Q · filed 2017-08-07 | $2.02M derived: sum of 3 quarters · filed 2018-08-13 | $2.63M derived: sum of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | $360.70K 10-Q · filed 2018-05-15 | $360.70K 10-Q · filed 2017-06-21 | $959.28K derived: sum of 2 quarters · filed 2018-05-15 | $1.56M derived: sum of 3 quarters · filed 2018-05-15 | $2.06M derived: sum of 4 quarters · filed 2018-05-15 | |
| 2016-12-31 | $598.58K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $1.20M derived: sum of 2 quarters · filed 2018-03-20 | $1.70M derived: sum of 3 quarters · filed 2018-03-20 | $2.07M 10-K · filed 2018-03-20 | ||
| 2016-09-30 | $605.11K 10-Q · filed 2017-11-14 | $1.10M derived: sum of 2 quarters · filed 2017-11-14 | $1.47M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $494.31K 10-Q · filed 2017-08-07 | $867.77K 10-Q · filed 2017-08-07 | ||||
| 2016-03-31 | $373.46K 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |